Abstract:The DNA binding and cross-linking modes of a trinuclear platinum Complex [Pt3Cl3(hptab)][ClO4](3) (1; hptab = N,N,N',N',N '',N ''-hexakis(2-pyridylmethyl)-1,3,5-tris(aminomethyl)benzene) and its dinuclear analogue [Pt2Cl2(m-tpxa)]Cl-2 (2; m-tpxa = N,N,N',N'-tetra(2-pyridylmethyl)-m-xylylene diamine) are reported and compared. The adducts of 1 and 2 with 18-mer duplex N1, 5'-d(GAAGAAGTCA-CAAAATGT)-3'center dot 5'-d(ACATTTTGT-GACTTCTTC)-3', have been characterized by means of denaturing polyacrylamide gels, Maxam-Gilbert sequencing, and MALDI-TOF mass spectrometry combined with enzymatic degradation to obtain insights into Structural features responsible for the differences in their antitumor activities. The cytotoxic-active complex 1 readily forms various DNA adducts, such as through 1,3- and 1,4-intrastrand cross-links, and in particular, the unique and unprecedented interstrand cross-linked triadducts. In contrast, the cytotoxic-inactive complex 2 preferentially forms 1,4-intrastrand rather than 1,3-intra- and -interstrand cross-links. Digestion of the DNA adducts of 1 shows that the cleavage is completely blocked at one nucleotide before the cross-linked guanine residues on the opposite strand, a feature that appears to be unprecedented in antitumor platinum complexes. In the case of 2, the cleavage bypasses the first platinated guanine site and stops at one nucleotide prior to the second platinated site, confirming that very few 1,3-intrastrand cross-links are formed by 2. These results are supported by molecular-modeling studies of intra- and interstrand cross-links Of duplex NI with 1 and 2. The remarkable differences between 1 and 2 in DNA binding and cross-linking provide mechanistic insights into their different cytotoxicity against the tumor cell lines; these insights are useful for designing future antitumor agents.

Sequence-Dependent Bending of DNA Induced by Cisplatin: NMR Structures of an A⋅T-Rich 14-Mer Duplex

Molecular Dynamics Studies of Changes in the DNA- Structure as Result of Interactions with Cisplatin

Platination of A Gg Site on Single-Stranded and Double-Stranded Forms of A 14-Base Oligonucleotide with Diaqua Cisplatin Followed by Nmr and Hplc - Influence of the Platinum Ligands and Base Sequence on 5'-G Versus 3'-G Platination Selectivity

Structural Transitions of A Gg-Platinated Dna Duplex Induced by Ph, Temperature and Box A of High-Mobility-Group Protein 1

Platinum Anticancer Drug Damage Enforces a Particular Rotational Setting of DNA in Nucleosomes

A New Platinum Anticancer Drug Forms a Highly Stereoselective Adduct with Duplex DNA

Differences in Conformational Dynamics of [Pt3(hptab)]6+-Dna Adducts with Various Cross-Linking Modes.

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

Theoretical Investigation of Interaction Between Unclassical Trinuclear Antitumor Platinum Complex and DNA Duplex

Discovery Of Cisplatin Binding To Thymine And Cytosine On A Single-Stranded Oligodeoxynucleotide By High Resolution Ft-Icr Mass Spectrometry

Structure and Mechanism of Human DNA Polymerase Η

T4 Endonuclease VII Cleaves DNA Containing a Cisplatin Adduct

Structural Basis for the Structure-Activity Behaviour of Oxaliplatin and its Enantiomeric Analogues: A Molecular Dynamics Study of Platinum-DNA Intrastrand Crosslink Adducts

Folding Kinetics of Single Human Telomeric G-Quadruplex Affected by Cisplatin

Interactions with DNA Models of the Oxaliplatin Analog (cis-1,3-DACH)PtCl2

Structural changes of linear DNA molecules induced by cisplatin.

The phosphate clamp: sequence selective nucleic acid binding profiles and conformational induction of endonuclease inhibition by cationic Triplatin complexes

Structure of Cis-[Pt(Nh3)(2-Picoline)](2+) and Dna Adduct and Its Bonding Characteristics

Dna Cross-Linking Patterns Induced by an Antitumor-Active Trinuclear Platinum Complex and Comparison with Its Dinuclear Analogue

Theoretical Study On The Factors That Affect The Structure And Stability Of The Adduct Of A New Platinum Anticancer Drug With A Duplex Dna

Nmr-Study on the Solution Structure of D-Tgggt